Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis

<p>Esophageal cancer (EC) is frequently considered a lethal malignancy and is often identified at a later stage. It is one of the major causes of cancer-related deaths globally. The conventional treatment methods like chemotherapy, radiotherapy, and surgery offer limited efficacy and poor clin...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Tarang Sharma (14150952) (author)
مؤلفون آخرون: Ashna Gupta (14150955) (author), Ravi Chauhan (14150958) (author), Ajaz A. Bhat (12984701) (author), Sabah Nisar (12561961) (author), Sheema Hashem (14150961) (author), Sabah Akhtar (5809925) (author), Aamir Ahmad (233201) (author), Mohammad Haris (564809) (author), Mayank Singh (793077) (author), Shahab Uddin (154400) (author)
منشور في: 2022
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513567927042048
author Tarang Sharma (14150952)
author2 Ashna Gupta (14150955)
Ravi Chauhan (14150958)
Ajaz A. Bhat (12984701)
Sabah Nisar (12561961)
Sheema Hashem (14150961)
Sabah Akhtar (5809925)
Aamir Ahmad (233201)
Mohammad Haris (564809)
Mayank Singh (793077)
Shahab Uddin (154400)
author2_role author
author
author
author
author
author
author
author
author
author
author_facet Tarang Sharma (14150952)
Ashna Gupta (14150955)
Ravi Chauhan (14150958)
Ajaz A. Bhat (12984701)
Sabah Nisar (12561961)
Sheema Hashem (14150961)
Sabah Akhtar (5809925)
Aamir Ahmad (233201)
Mohammad Haris (564809)
Mayank Singh (793077)
Shahab Uddin (154400)
author_role author
dc.creator.none.fl_str_mv Tarang Sharma (14150952)
Ashna Gupta (14150955)
Ravi Chauhan (14150958)
Ajaz A. Bhat (12984701)
Sabah Nisar (12561961)
Sheema Hashem (14150961)
Sabah Akhtar (5809925)
Aamir Ahmad (233201)
Mohammad Haris (564809)
Mayank Singh (793077)
Shahab Uddin (154400)
dc.date.none.fl_str_mv 2022-11-22T21:12:59Z
dc.identifier.none.fl_str_mv 10.1007/s10555-022-10026-6
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Cross-talk_between_the_microbiome_and_chronic_inflammation_in_esophageal_cancer_potential_driver_of_oncogenesis/21597201
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Oncology and carcinogenesis
Cancer Research
Oncology
dc.title.none.fl_str_mv Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p>Esophageal cancer (EC) is frequently considered a lethal malignancy and is often identified at a later stage. It is one of the major causes of cancer-related deaths globally. The conventional treatment methods like chemotherapy, radiotherapy, and surgery offer limited efficacy and poor clinical outcome with a less than 25% 5-year survival rate. The poor prognosis of EC persists despite the growth in the development of diagnostic and therapeutic modalities to treat EC. This underlines the need to elucidate the complex molecular mechanisms that drive esophageal oncogenesis. Apart from the role of the tumor microenvironment and its structural and cellular components in tumorigenesis, mounting evidence points towards the involvement of the esophageal microbiome, inflammation, and their cross-talk in promoting esophageal cancer. The current review summarizes recent research that delineates the underlying molecular mechanisms by which the microbiota and inflammation promote the pathophysiology of esophageal cancer, thus unraveling targets for potential therapeutic intervention.</p><h2>Other Information</h2> <p> Published in: Cancer and Metastasis Reviews<br> License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1007/s10555-022-10026-6" target="_blank">http://dx.doi.org/10.1007/s10555-022-10026-6</a></p>
eu_rights_str_mv openAccess
id Manara2_c061db35bda21a5e744d6c609284e9a2
identifier_str_mv 10.1007/s10555-022-10026-6
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/21597201
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesisTarang Sharma (14150952)Ashna Gupta (14150955)Ravi Chauhan (14150958)Ajaz A. Bhat (12984701)Sabah Nisar (12561961)Sheema Hashem (14150961)Sabah Akhtar (5809925)Aamir Ahmad (233201)Mohammad Haris (564809)Mayank Singh (793077)Shahab Uddin (154400)Oncology and carcinogenesisCancer ResearchOncology<p>Esophageal cancer (EC) is frequently considered a lethal malignancy and is often identified at a later stage. It is one of the major causes of cancer-related deaths globally. The conventional treatment methods like chemotherapy, radiotherapy, and surgery offer limited efficacy and poor clinical outcome with a less than 25% 5-year survival rate. The poor prognosis of EC persists despite the growth in the development of diagnostic and therapeutic modalities to treat EC. This underlines the need to elucidate the complex molecular mechanisms that drive esophageal oncogenesis. Apart from the role of the tumor microenvironment and its structural and cellular components in tumorigenesis, mounting evidence points towards the involvement of the esophageal microbiome, inflammation, and their cross-talk in promoting esophageal cancer. The current review summarizes recent research that delineates the underlying molecular mechanisms by which the microbiota and inflammation promote the pathophysiology of esophageal cancer, thus unraveling targets for potential therapeutic intervention.</p><h2>Other Information</h2> <p> Published in: Cancer and Metastasis Reviews<br> License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1007/s10555-022-10026-6" target="_blank">http://dx.doi.org/10.1007/s10555-022-10026-6</a></p>2022-11-22T21:12:59ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1007/s10555-022-10026-6https://figshare.com/articles/journal_contribution/Cross-talk_between_the_microbiome_and_chronic_inflammation_in_esophageal_cancer_potential_driver_of_oncogenesis/21597201CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/215972012022-11-22T21:12:59Z
spellingShingle Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis
Tarang Sharma (14150952)
Oncology and carcinogenesis
Cancer Research
Oncology
status_str publishedVersion
title Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis
title_full Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis
title_fullStr Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis
title_full_unstemmed Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis
title_short Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis
title_sort Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis
topic Oncology and carcinogenesis
Cancer Research
Oncology